.gif)
The U.S. Food and Drug Administration approved Descovy (emtricitabine 200 mg and tenofovir alafenamide 25 mg) in at-risk adults and adolescents weighing at least 35kg for HIV-1 pre-exposure prophylaxis (PrEP) to reduce the risk of HIV-1 infection from sex, excluding those who have receptive vaginal sex. Descovy is not indicated in individuals at risk of HIV-1 infection from receptive vaginal sex because the effectivness in this population has not been evaluated.
(adsbygoogle = window.adsbygoogle || []).push({});
Of an estimated 6,500 to 7,000 known rare diseases, only a fraction – maybe 5% – have U.S. Food and Drug Administration-approved treatments. To increase that percentage, the National Institutes of Health has awarded approximately $31 million in grants in fiscal year 2019 to 20 teams – including five new groups -- of scientists, clinicians, patients, families and patient advocates to study a wide range of rare diseases. An additional $7 million has been awarded to a separate data coordinating center to support these research efforts.
Children born to women who have high blood levels of lead are more likely be overweight or obese, compared to those whose mothers have low levels of lead in their blood, according to a study funded by the National Institutes of Health and Health Resources and Services Administration. The study was conducted by Xiaobin Wang, M.D., of the Johns Hopkins Bloomberg School of Public Health in Baltimore, and colleagues. It appears in JAMA Network Open.
IIHMR University will celebrate its 35th Foundation day on 5th October 2019. Apart from the much-awaited cultural program and alumni meet, IIHMR U is all set to utilize the prestigious occasion of its 35th Foundation Day to desensitize and wake young minds up to the perils of Diabetes. India is in a precarious situation as the rise of Non-communicable diseases such as diabetes are pushing the nation’s complete health goals far behind.
Do Not Forget to Verify
(Click on Subscription link in your inbox)
--------
Also Join: 
.png)
